Concepedia

Amber Umble-Romero

AU

3

Publications

67

Citations

3

H-Index

2014

Active since

Affiliations

Amgen (United States)(Current)

Amber Umble-Romero is an author at Amgen (United States) specializing in clinical chemistry, drug discovery, and medical laboratory science.

Top concepts

Publications per year

2014–2014

3

Publications

3

Preclinical development of<scp>AMG</scp>139, a human antibody specifically targeting<scp>IL</scp>‐23

Kathleen Köck, W. Pan, Jason M. Gow et al. · British Journal of Pharmacology · 2014 · 31 citations · Full text

Characterization of a quantitative method to measure free proprotein convertase subtilisin/kexin type 9 in human serum

Alexander Colbert, Amber Umble-Romero, Samantha P. Prokop et al. · mAbs · 2014 · 19 citations · Full text

, , +21

Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs

Alex Colbert, Amber Umble-Romero, Samantha P. Prokop et al. · mAbs · 2014 · 17 citations · Full text

, , +19

Rows per page

1–3 of 3